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Objective: To address the minimum duration of pulmonary rehabilitation necessary for
patients with chronic obstructive pulmonary disease (COPD) to achieve a plateau in Health-
Related Quality of Life (HRQL) and exercise tolerance.
Methods: COPD patients with a dyspnea rating of at least 2 on the Medical Research Council
scale participated in an outpatient rehabilitation program of 3 weekly sessions for 12 weeks.
Measurements included HRQL and exercise tolerance 2 weeks before the program started
and every 2 weeks thereafter. Patients were considered to have reached a plateau if they
showed no improvement beyond 20% of the minimal important difference between 2 consec-
utive evaluations on HRQL score or walk tests.
Results: Twenty-eight patients participated. The number of patients achieving stability after 8
weeks, showing continued improvement after 8 weeks, and demonstrating an erratic pattern
of change was as follows: for physical function 16 (56%), 10 (37%) and 2 (7%) patients; for
emotional function 22 (79%), 5 (18%) and 1 (4%); and for 6-min walk test 21 (75%), 5 (18%)
and 2 (7%). More severe patients demonstrated a greater likelihood (76%) of achieving stability
in physical function at 12 weeks than did less severe patients (27%; p on differenceZ 0.003).
The likelihood of stability at 12 weeks in emotional function and the 6-min walk test did not
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Duration of pulmonary rehabilitation in COPD 723Conclusions: A program of 3 weekly 3-h sessions of outpatient pulmonary rehabilitation
program should last at least 8 weeks in order to achieve optimal HRQL and exercise tolerance
for most patients.
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Pulmonary rehabilitation improves exercise tolerance and
health-related quality of life (HRQL) in patients with
chronic obstructive pulmonary disease (COPD).1e10 No
consensus has emerged, however, regarding the optimal
duration of the initial intense phase of rehabilitation.
Some authors have recommended programs of 3e5
sessions per week for 2e3 months.2,12,13 The most recent
reviews of pulmonary rehabilitation by the American
Thoracic Society and the European Thoracic Society13 in
2006, and the American College of Chest Physicians in
2007,1 called attention to the lack of evidence regarding
optimal duration. The reviews nevertheless suggested the
duration of effect is directly proportional to the duration of
the program. Some evidence, however, suggests that
shorter programs may be as effective as longer ones.14,15
Authors of a recent meta-analysis of 20 randomized
controlled trials (RCTs) in 999 patients concluded that
patients diagnosed with mild-to-moderate COPD could
benefit from short rehabilitation programs, whereas those
with severe disease needed at least 6 months to achieve
the same benefits.16
We hypothesized that the results of a pulmonary reha-
bilitation program could be evaluated based on serial
measurements of HRQL and the 6-min walk test. Our aim
was to establish the minimum time an outpatient pulmo-
nary rehabilitation program should last to allow patients
with moderate-to-severe COPD to achieve stability after
initial improvement.
Methods and material
Study design
This is a longitudinal cohort study, in which we followed
a group of COPD patients from 2 weeks before entering an
outpatient rehabilitation program until the end of this
program. We measured patients’ health-related quality of
life (HRQL) using the Chronic Respiratory Questionnaire
(CRQ) and their 6-min walk test distance every two weeks.
Patients
Patients were recruited from among those attending our
hospital’s outpatient clinic if they had COPD diagnosed
according to the criteria of the Global Initiative for Chronic
Obstructive Lung Disease (GOLD).17 Inclusion criteria were
age under 65 years, shortness of breath rated as 2 or more
on a modified Medical Research Council (MRC) scale,18 no
need for home oxygen therapy, clinically stable nutritional
status, no exacerbation in the last month or changes in
medication in the last 4 months, and written informed
consent to participate in the study.All patients used an inhaled corticosteroid and an
inhaled b2-agonist and/or an anti-cholinergic agent. Five
patients with moderate COPD who had experiences at less 2
exacerbations last year used inhaled corticosteroid
according to the judgment of their physicians.
Exacerbation, defined by the presentation of productive
cough, purulent sputum, and increased shortness of breath
in accordance with the criteria of Anthonisen et al.19 were
grounds for withdrawal from the program.
The local institutional review board approved the study.
Methods
Patients who met the aforementioned criteria were
enrolled in an intensive 12-week outpatient pulmonary
rehabilitation program.
Patients completed HRQL questionnaire and tests of
exercise tolerance 2 weeks before starting the rehabilita-
tion program (baseline), just before starting, and every 2
weeks thereafter. HRQL was assessed with a validated
Spanish translation of the CRQ,20 which consists of 20
questions that can be aggregated in 2 domains: physical
function (including dyspnea e 5 questions and fatigue e 4
questions), and emotional function (including emotions e 7
questions e and mastery over disease e 4 questions). Each
question was scored on scale of 1 (worst function)e7 (best),
as was each domain. A change of 0.5 points or more per
domain was considered important.21 At the initial assess-
ment of exercise tolerance the 6-min walk test22 was
repeated 3 times on consecutive days or after a rest period
of more than 1 h in order to record the best of 3 distances.
A walk test improvement of 54 m or more was considered
important.23
Outpatient pulmonary rehabilitation program
Patients attended the rehabilitation center 3 days a week
for 12 weeks. To optimize the use of respiratory muscles,
a physiotherapist taught respiratory exercises during the
first week. All patients received instruction regarding
relaxation techniques, and those with significant sputum
production received instruction on techniques to remove
secretions. Lower extremity muscle training, which began
in the second week, utilized a cycle ergometer in 30-min
sessions at an initial load that represented 60% of the
maximum load reached during an incremental exercise
test. The exercise load was increased in keeping with
tolerance. Upper extremity muscle training, also carried
out in 30-min sessions, began with half-kilogram weights for
each arm. The weight increased by 1 kg each week until
patients reached maximum tolerance. Inspiratory and
expiratory muscle training sessions lasted 15 min each with
the patient breathing through a threshold resistive loading
device (Threshold, Respironics, Cedar Grove, NJ, USA) with
Table 1 Patient characteristics at baseline.a
Variable Mean SD Minimum Maximum
Age, year 62.8 9.7 37 74
BMI, kg/m2 25.2 3.2 20 33.2
Upper arm
circumference, cm
29.9 8.3 24 70
Triceps skin fold, cm 13 5 6 25
Albumin, g/L 43 3 38 48
FEV1 pbd, % predicted 36 15 17 70
FEV1 pbd 35% (nZ 17) 26 7 17 34
FEV1 pbd> 35% (nZ 11) 51 11 38 70
FVC pbd, % predicted 72 17 42 104
FEV1/FVC pbd, % 35 8.9 19 66
TLC, % predicted 114 15 80 141
RV, % predicted 185 42 96 262
Kco, % predicted 59 19 24 96
PImax, % predicted 96 27 40 133
PEmax, % predicted 117 40 34 195
PaO2, mmHg 74 10 55 95
PaCO2, mmHg 41 4.7 33 54
Dyspnea rating,
MRC 1e5b
2.8 0.7 2 4
6MWT, m 399 82.5 250 550
Wmax, kpm 547 170 300 900
VO2max, mL 0.58 0.26 0.19 1.09
CRQ scoresc
Total 16.51 3.56 9.44 21.77
Dyspnea 3.04 0.75 1.40 4.40
Fatigue 4.20 0.98 2.50 6.00
Emotion 4.49 1.17 1.86 6.00
Mastery 4.79 1.30 2.25 7.25
a BMIZ body mass index; FEV1Z forced expiratory volume in
1 second; FVCZ forced vital capacity; pbdZ post-
bronchodilator; TLCZ total lung capacity; RVZ residual
volume; KcoZ carbon monoxide transfer coefficient; PImaxZ
maximal inspiratory pressure; PEmaxZmaximal expiratory
pressure; MRCZMedical Research Council; 6MWTZ 6-min walk
test; WmaxZwork capacity; VO2maxZmaximal oxygen
consumption; CRQZ Chronic Respiratory Questionnaire.
b The score on the MRC ranges from 1 (best situation) to 5
(worst).
c The total score on the Chronic Respiratory Questionnaire
ranges from 4 (worst situation) to 28 (best); each domain score
ranges from 1 (worst situation) to 7 (best).
724 I. Solanes et al.a valve set to provide a pressure at least 30% of the
maximum inspiratory pressure. The program included
information sessions to explain the nature of the disease
and ensure correct inhaler technique.
Statistical analysis
We chose a sample size based on resource and feasibility
considerations rather than a formal sample size
calculation.
Data were expressed as mean SD. Analysis of variance
of repeated measures was applied to the CRQ and the 6-min
walk tests recorded at 2-week intervals for patients who
finished the program. We reasoned that, for both the CRQ
and the walk test, if a patient showed no improvement
beyond 20% of the minimal important difference (MID) then
the patient had achieved all the improvement possible
through rehabilitation as reflected in that outcome
measure. We considered the MID for the both the physical
and emotional function domains of the CRQ as 0.521 and
therefore considered patients to have achieved full benefit
when 2 successive measurements showed no improvement
beyond 0.1 points. For the walk test, we considered the MID
to be 54 m23 and therefore considered that maximum
benefit had been achieved if 2 successive 6-min walk tests
showed no improvement beyond 10.8 m.
We classified patients as manifesting erratic behavior if
the patient manifested deterioration in either walk test or
CRQ of more than 10% in comparison to the previous
measure on more than one occasion. We chose 10% as
a threshold because it represents the coefficient of varia-
tion on 6-min walk test in our institution.
On the basis of previous results suggesting that optimal
duration of rehabilitation may vary with the severity of
COPD,16 we examined our results according to whether
FEV1 was 35% or >35%. We conducted a Fisher’s exact test
to determine whether chance could explain the differences
in the proportion of patients achieving stability by 12 weeks
in the more and less severe patients.
Results
Of the 36 patients recruited, 2 withdrew before starting
rehabilitation because of family- or work-related diffi-
culties and 6 left during the course of the program: 1
because of starting continuous positive airway pressure
treatment at 2 weeks and 5 due to exacerbation of
disease requiring a treatment change or hospital
admission. The analysis is therefore based on data from
28 patients.
Patient characteristics
Twenty-four of the 28 patients (86%) were men. The mean
age of patients enrolled was 63 9.7 years. According to
GOLD criteria,17 5 patients (18%) had moderate COPD, 11
(39%) had severe disease, and 12 (43%) had very severe
disease. The MRC score 18 was 2 for 10 patients (36%), 3 for
14 patients (50%), and 4 for 4 patients (14%). All were in
a state of good nutrition. Table 1 shows patient baseline
characteristics.Seven patients (25%) improved on both domains of CRQ
and on the 6-min walk test (4 of them at 4th week, 1 at 8th
week and 2 at 10th week). Eleven patients (39%) improved
in two of the outcomes (the 2 CRQ domains and the walk
test) (1 of them at 2nd week, 4 at 6th week, 3 at 8th week
and 3 at 10th week). Two (7%), 2(7%) and 4 (14%) patients
only improved in one of three outcomes. Two patients (7%)
didn’t improve on any outcome.
HRQL
The mean change between baseline and the final evalua-
tion of the CRQ physical function domain was 1.11 points
(p< 0.001 on analysis of variance considering all
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Figure 1 Improvement in health-related quality of life
during a pulmonary rehabilitation program of 3 sessions every
week. Patients were assessed 2 weeks before starting (base-
line), just before starting rehabilitation, and every 2 weeks
throughout the 12-week program. Scores of physical and
emotional domains of the Chronic Respiratory Questionnaire
(CRQ).
Duration of pulmonary rehabilitation in COPD 725measurements). The physical component score at baseline
(2 weeks before the first session) was 3.55 0.76 points.
Mean CRQ physical function had improved by more than 0.5
points by 4 weeks (mean value 4.23 1.01 points). Mean
scores changed little between 4 and 8 weeks and then
continued improving, on the last evaluation the score
reached was 4.66 0.97 points (Fig. 1).
Sixteen patients (57%) achieved stability with respect to
physical function at 8 weeks. Ten patients (36%) did not
achieve the stability at 8 weeks and two patients (7%)
showed an erratic pattern of results.Table 2 Number of patients exceeding minimal important diffe
2 weeks 4 weeks 6 weeks 8 wee
Physical 9 4 1
Emotional 4 9 0 4
6MWT 4 5 3 3
PhysicalZ physical function (including dyspneaþ fatigue on CRQ [Chr
(including emotions and mastery over disease on CRQ); 6MWTZ 6-miThe mean change between baseline and the final eval-
uation of the CRQ emotional function was 0.86 points
(p< 0.001 on analysis of variance). The emotional compo-
nent score at baseline (2 weeks before the first session) was
4.60 1.09 points. A mean improvement of greater than
0.5 points was seen at 6 weeks, when the score reached
5.26 1.04 points. Mean score was stable between 6 and 8
weeks; scores on the last evaluation showed further
improvement (5.46 1.07 points) (Fig. 1).
Twenty-two patients (79%) achieved stability at 8 weeks
of the program. Five patients (18%) did not achieve stability
and one patient (4%) showed an erratic pattern of results.
Table 2 shows the number of patients exceeding the
minimal important difference in improvement in HRQL on
each determination.
Six-min walk test
The mean change between baseline and the final evalua-
tion on six-min walk test was 83.9 m (p< 0.001 on analysis
of variance). The mean distance walked at baseline (2
weeks before the first session) was 390 95 m. The
distance increased gradually and a mean value more than
50 m greater than baseline was observed at 6 weeks (mean
distance walked 449 97 m). Distance walked continued to
improve reaching 469 90 m after 8 weeks, after which
mean distance showed little change. On the last evalua-
tion, after twelve weeks, the mean distance walked was
473 96 m (Fig. 2).
Twenty one patients (75%) achieved stability at 8 weeks.
Five patients (18%) continued to improve and two (7%)
manifested erratic scores.
Table 2 shows the number of patients exceeding minimal
important difference in improvement in the 6-min walk test
at each determination.
Pattern of response according to COPD severity
Among 17 COPD patients with FEV1 35%, 13 (76%) ach-
ieved stability at 12 weeks in the physical and emotional
function domain of the CRQ and 12 (71%) on the 6-min walk
test.
Among 11 COPD patients with FEV1> 35%, 3 (27%) ach-
ieved stability on physical function domain of the CRQ and 9
(81%) on the emotional function domain and 6-min walk
test at 12 weeks.
Chance is unlikely to explain the difference in frequency
of stability at 12 weeks in CRQ physical function between
patients with FEV1 35% (76%) and patients withrence at each measured point.
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Figure 2 Improvement in exercise tolerance during
a pulmonary rehabilitation program of 3 sessions per week.
Patients were assessed 2 weeks before starting (baseline), just
before starting rehabilitation, and every 2 weeks throughout
the 12-week program.
726 I. Solanes et al.FEV1> 35% (27%) (pZ 0.003). Differences between the two
groups in emotional function and the 6-min walk test are
easily explained by chance.
Discussion
We found patients with COPD completing an outpatient
pulmonary rehabilitation program of 3 sessions per week for
12 weeks demonstrated improvement in HRQL and exercise
tolerance. The majority of patients reached a plateau in
physical function (57%), emotional function (79%), and walk
test performance (75%) at 8 weeks.
Most of patients who achieved the stability during the
program had achieved the MID before 6 weeks. Not all
patients achieved the MID on each of the two domains of
the CRQ and on the 6-min walk test, but almost all achieved
the MID in one or more outcomes by the end of the program
(Table 2).
The ATS/ERS13 recommended 20 sessions and the ACCP/
AACVPR statement1 suggests that programs of 6e12 weeks
are beneficial. A single prior study including 13 COPD
patients24 used a design similar to ours to address the
trajectory of changes in treadmill endurance and CRQ over
a 12-week rehabilitation program (24 sessions). The authors
conclude that 20 sessions are needed to reach optimal
acute changes in exercise performance, but improvements
in quality of life may occur earlier. While limited relative to
our study in the smaller sample size, and the lack of focus
on individuals, these authors’ results are consistent with
ours.
Other prior studies address the optimal duration of
rehabilitation by making direct comparisons of specific
alternative durations with the same intensity of interven-
tion throughout. Berry et al.25 conducted an RCT comparing
a 3-month program versus 18 months. Patients in both
programs achieved their greatest gains in self-reported
disability and physical function at 3 months. However,
patients in the longer program showed less disability and
better physical function at 18 months. Sewell et al.26undertook an RCT in patients with COPD to assess whether
a 4 weeks pulmonary rehabilitation program was equivalent
to conventional 7 weeks pulmonary rehabilitation program.
The authors found no important differences between the
programs at 7 weeks and 6 months. Foy et al.27 conducted
an RCT comparing 3 months of exercise training to 18
months. Men, but not women, experienced greater benefit
with the longer program.
Programs with fewer than 2 weekly sessions some-
times,28 but not always,15 led to minimal improvement in
health status and the 6-min walk test. Most programs that
have shown benefit in RCTs conducted more frequent
training sessions. Thus, although the evidence is meager,
one might expect patients to reach a plateau more rapidly
with programs with greater frequency of training sessions.
The ATS/ERS statement13 suggests programs should offer at
least three sessions per week to achieve physiologic
benefit. They qualify this recommendation by stating that
twice-weekly supervised plus one unsupervised home
session may also acceptable.
There are three RCTs addressing the influence of training
intensity on the benefits reached by the pulmonary reha-
bilitation program. Gimenez et al.29 and Vallet et al.30
found that higher intensity training in COPD patients
resulted in a greater physiologic improvements than low-
intensity training. Normandin et al.31 compared, in
a randomized trial, the short-term effectiveness high-
intensity program with a lower-intensity one. The
high-intensity group trained on a stationary bicycle and
treadmill and the lower-intensity group performed class-
room exercises. Both groups participated in twice-weekly
sessions for 8 weeks. The high-intensity group showed
greater increases in treadmill endurance and greater
reductions in exertional dyspnea, and low-intensity showed
greater increases in arm endurance. Both groups had
similar improvements in overall dyspnea, functional
performance and health status. The differences between
groups may have been due as much or more to differences
in the muscular groups trained training rather than differ-
ences in intensity training.
No study has addressed the effect of training intensity
on time to maximal improvement. The ACCP/AACVPR
statement1 suggests that high and low-intensity training are
beneficial. Moreover, whether program intensity influences
the rapidity with which patients reach a plateau remains
uncertain.
Finally, disease severity may influence the rapidity with
which patients’ reach their optimal status. Wedzicha
et al.32 found that patients with a high degree of dyspnea
(MRC rating of 5) obtained less benefit from rehabilitation
than patients with mild or moderate dyspnea. The authors
speculated that it is possible that patients with more severe
dyspnea may require longer or more intense training. These
results are consistent with the meta-analysis of Salman
et al.16 The authors analyzed 20 RCTs with a total of 999
symptomatic COPD patients and concluded that mild and
moderate COPD (FEV1> 35%) patients obtain benefits from
short and long rehabilitation programs while severe COPD
(FEV1 35%) patients need at least 6 month of rehabilita-
tion. Our results do not, however, support the conclusion of
Salman et al. meta-analysis. A substantially larger propor-
tion of patients with more severe COPD in our study
Duration of pulmonary rehabilitation in COPD 727achieved stability in CRQ physical function by 12 weeks
than did patients with less severe COPD. We found no
differences in time to stability in both groups in either CRQ
emotional function or 6-min walk test distance.
These studies demonstrate that factors other than the
duration of the program can determine the point at which
patients have reached a plateau in the benefits from the
pulmonary rehabilitation. These factors include session
frequency, training intensity and severity of the disease.
The optimal balance between intensity, frequency and
duration remains unclear and requires further study.
The most important strengths of this study are the
careful repeated measurement of functional exercise
capacity and HRQL, the rigorous analyses focusing both on
the total patient group and on individuals. Our study has
three important limitations. First, the sample size is small.
Second, approximately 25% of the patients were still
apparently improving at 12 weeks. When such patients
would have reached their plateau remains uncertain. Third,
it is possible that continuing the intensive phase of reha-
bilitation after patients reach a plateau may impact on the
long-term benefits, and the persistence of those benefits.
Nevertheless, our results support a conclusion that an 8
week outpatient pulmonary rehabilitation program with 3
sessions per week is sufficiently long for most patients with
moderate-to-severe COPD (GOLD class, IIeIV) and dyspnea
(MRC rating, 2e4), to reach a plateau in HRQL and walk test
distance. A minority of patients will continue to demon-
strate improvement after 8 weeks, and for at least as long
as 12 weeks.
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